Neurogram

About Neurogram

Neurogram develops an AI-driven platform that analyzes EEG data to identify neuro-biomarkers for neurological diseases, including epilepsy and Alzheimer's. This technology enhances diagnostic accuracy and reduces the time and costs associated with evaluating complex neurological conditions in critical care settings.

Neurogram develops an AI-driven platform that analyzes EEG data to identify neuro-biomarkers for neurological diseases, including epilepsy and Alzheimer's. This technology enhances diagnostic accuracy and reduces the time and costs associated with evaluating complex neurological conditions in critical care settings.

What does Neurogram do?

Neurogram develops an AI-driven platform that analyzes EEG data to identify neuro-biomarkers for neurological diseases, including epilepsy and Alzheimer's. This technology enhances diagnostic accuracy and reduces the time and costs associated with evaluating complex neurological conditions in critical care settings.

Where is Neurogram located?

Neurogram is based in Atlanta, United States.

When was Neurogram founded?

Neurogram was founded in 2021.

Who founded Neurogram?

Neurogram was founded by Daniele De Mari.

  • Daniele De Mari - CEO
Location
Atlanta, United States
Founded
2021
Employees
15 employees
Investors
Starship

Neurogram

4
Relative Traction Score based on online presence metrics compared to companies in the same age group.

Executive Summary

Neurogram develops an AI-driven platform that analyzes EEG data to identify neuro-biomarkers for neurological diseases, including epilepsy and Alzheimer's. This technology enhances diagnostic accuracy and reduces the time and costs associated with evaluating complex neurological conditions in critical care settings.

neurogram.com700+
Founded 2021 – Atlanta, United States

Funding

Backed by

Starship

Team (15+)

Daniele De Mari

CEO

Anderson Carubelli

Chief Technology Officer

Paula Gentil

“Do the best you can until you know better. Then when you know better, do better.”

Company Description

Neurogram develops an AI-driven platform that analyzes EEG data to identify neuro-biomarkers for neurological diseases, including epilepsy and Alzheimer's. This technology enhances diagnostic accuracy and reduces the time and costs associated with evaluating complex neurological conditions in critical care settings.

Sources:

1
This profile is AI-generated from web data and may contain inaccuracies. Want to correct or remove an entry? Owners can claim edits via their company email domain, and signed-in users can submit sourced suggestions.